Profile | GDS5420 / 204298_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 31.95 | 25 |
GSM1296119 | B_lesional_pre-dose | 295.19 | 59 |
GSM1296076 | C_lesional_pre-dose | 109.61 | 44 |
GSM1296092 | D_lesional_pre-dose | 99.96 | 44 |
GSM1296103 | E_lesional_pre-dose | 77.3 | 38 |
GSM1296078 | F_lesional_pre-dose | 125.54 | 47 |
GSM1296107 | G_lesional_pre-dose | 126.33 | 44 |
GSM1296109 | H_lesional_pre-dose | 110.93 | 41 |
GSM1296080 | I_lesional_pre-dose | 86.84 | 41 |
GSM1296090 | J_lesional_pre-dose | 317.98 | 61 |
GSM1296074 | K_lesional_pre-dose | 180.36 | 53 |
GSM1296111 | L_lesional_pre-dose | 297.25 | 59 |
GSM1296099 | M_lesional_pre-dose | 91.58 | 40 |
GSM1296086 | O_lesional_pre-dose | 95.88 | 42 |
GSM1296117 | P_lesional_pre-dose | 100.2 | 39 |
GSM1296113 | Q_lesional_pre-dose | 108.06 | 39 |
GSM1296096 | R_lesional_pre-dose | 55.92 | 33 |
GSM1296105 | S_lesional_pre-dose | 69.96 | 35 |
GSM1296098 | T_lesional_pre-dose | 43.94 | 26 |
GSM1296101 | U_lesional_pre-dose | 79.34 | 37 |
GSM1296121 | V_lesional_pre-dose | 96.74 | 40 |
GSM1296088 | W_lesional_pre-dose | 48.33 | 31 |
GSM1296082 | X_lesional_pre-dose | 71.75 | 38 |
GSM1296115 | Y_lesional_pre-dose | 160.36 | 48 |
GSM1296084 | Z_lesional_pre-dose | 67.17 | 35 |
GSM1296072 | B_lesional_day8 | 148.45 | 46 |
GSM1296069 | L_lesional_day8 | 428.93 | 64 |
GSM1296071 | P_lesional_day8 | 215.3 | 52 |
GSM1296070 | Y_lesional_day8 | 274.72 | 56 |
GSM1296073 | V_lesional_day8 | 116.48 | 43 |
GSM1296034 | A_lesional_day15 | 10.81 | 10 |
GSM1296041 | G_lesional_day15 | 182.31 | 50 |
GSM1296035 | R_lesional_day15 | 99.82 | 42 |
GSM1296038 | U_lesional_day15 | 133.79 | 46 |
GSM1296047 | B_lesional_day15 | 95.96 | 39 |
GSM1296039 | E_lesional_day15 | 83.22 | 39 |
GSM1296042 | H_lesional_day15 | 248.46 | 55 |
GSM1296043 | L_lesional_day15 | 271 | 56 |
GSM1296037 | M_lesional_day15 | 76.69 | 36 |
GSM1296046 | P_lesional_day15 | 248.09 | 54 |
GSM1296044 | Q_lesional_day15 | 134.2 | 43 |
GSM1296045 | Y_lesional_day15 | 265.79 | 56 |
GSM1296025 | C_lesional_day15 | 49.21 | 31 |
GSM1296033 | D_lesional_day15 | 36.56 | 27 |
GSM1296027 | I_lesional_day15 | 63.47 | 37 |
GSM1296032 | J_lesional_day15 | 81.05 | 38 |
GSM1296024 | K_lesional_day15 | 53.83 | 33 |
GSM1296031 | W_lesional_day15 | 166.32 | 49 |
GSM1296028 | X_lesional_day15 | 43.56 | 29 |
GSM1296029 | Z_lesional_day15 | 120.53 | 44 |
GSM1296026 | F_lesional_day15 | 147.89 | 48 |
GSM1296030 | O_lesional_day15 | 68.22 | 38 |
GSM1296040 | S_lesional_day15 | 105.42 | 42 |
GSM1296036 | T_lesional_day15 | 46 | 28 |
GSM1296048 | V_lesional_day15 | 390.52 | 64 |
GSM1296059 | A_lesional_day43 | 154.16 | 49 |
GSM1296066 | G_lesional_day43 | 117.35 | 42 |
GSM1296060 | R_lesional_day43 | 54.26 | 33 |
GSM1296063 | U_lesional_day43 | 237.3 | 55 |
GSM1296064 | E_lesional_day43 | 168.59 | 50 |
GSM1296067 | H_lesional_day43 | 140.39 | 44 |
GSM1296062 | M_lesional_day43 | 24.86 | 22 |
GSM1296068 | Q_lesional_day43 | 232.12 | 53 |
GSM1296050 | C_lesional_day43 | 160.83 | 49 |
GSM1296057 | D_lesional_day43 | 285.99 | 58 |
GSM1296052 | I_lesional_day43 | 110.18 | 45 |
GSM1296054 | J_lesional_day43 | 70.47 | 35 |
GSM1296049 | K_lesional_day43 | 66.51 | 35 |
GSM1296055 | W_lesional_day43 | 579.65 | 70 |
GSM1296053 | X_lesional_day43 | 61.42 | 34 |
GSM1296058 | Z_lesional_day43 | 537.28 | 69 |
GSM1296051 | F_lesional_day43 | 185.62 | 52 |
GSM1296056 | O_lesional_day43 | 151.22 | 49 |
GSM1296065 | S_lesional_day43 | 285.62 | 58 |
GSM1296061 | T_lesional_day43 | 44.21 | 28 |
GSM1296095 | A_non-lesional_pre-dose | 142.58 | 48 |
GSM1296120 | B_non-lesional_pre-dose | 168.32 | 48 |
GSM1296077 | C_non-lesional_pre-dose | 84.12 | 40 |
GSM1296093 | D_non-lesional_pre-dose | 61.13 | 33 |
GSM1296104 | E_non-lesional_pre-dose | 101.48 | 41 |
GSM1296079 | F_non-lesional_pre-dose | 62.62 | 34 |
GSM1296108 | G_non-lesional_pre-dose | 135.4 | 45 |
GSM1296110 | H_non-lesional_pre-dose | 152.96 | 45 |
GSM1296081 | I_non-lesional_pre-dose | 151.27 | 49 |
GSM1296091 | J_non-lesional_pre-dose | 14.65 | 15 |
GSM1296075 | K_non-lesional_pre-dose | 148.2 | 49 |
GSM1296112 | L_non-lesional_pre-dose | 266.02 | 55 |
GSM1296100 | M_non-lesional_pre-dose | 36.01 | 26 |
GSM1296087 | O_non-lesional_pre-dose | 68.88 | 38 |
GSM1296118 | P_non-lesional_pre-dose | 74.25 | 33 |
GSM1296114 | Q_non-lesional_pre-dose | 120.38 | 42 |
GSM1296097 | R_non-lesional_pre-dose | 181.23 | 51 |
GSM1296106 | S_non-lesional_pre-dose | 82.38 | 37 |
GSM1296102 | U_non-lesional_pre-dose | 150.12 | 47 |
GSM1296122 | V_non-lesional_pre-dose | 134.05 | 44 |
GSM1296089 | W_non-lesional_pre-dose | 232.81 | 54 |
GSM1296083 | X_non-lesional_pre-dose | 145.16 | 47 |
GSM1296116 | Y_non-lesional_pre-dose | 138.52 | 44 |
GSM1296085 | Z_non-lesional_pre-dose | 64.47 | 35 |